Clear Harbor Asset Management’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $114K | Hold |
42,000
| – | – | 0.01% | 391 |
|
|
2025
Q1 | $94.5K | Hold |
42,000
| – | – | 0.01% | 382 |
|
|
2024
Q4 | $147K | Sell |
42,000
-1,500
| -3% | -$5.25K | 0.01% | 350 |
|
|
2024
Q3 | $179K | Hold |
43,500
| – | – | 0.01% | 332 |
|
|
2024
Q2 | $157K | Sell |
43,500
-2,500
| -5% | -$9K | 0.01% | 333 |
|
|
2024
Q1 | $152K | Sell |
46,000
-13,754
| -23% | -$45.4K | 0.01% | 338 |
|
|
2023
Q4 | $108K | Sell |
59,754
-4,000
| -6% | -$7.25K | 0.01% | 326 |
|
|
2023
Q3 | $82.2K | Buy |
63,754
+7,000
| +12% | +$9.03K | 0.01% | 314 |
|
|
2023
Q2 | $74.9K | Sell |
56,754
-24,000
| -30% | -$31.7K | 0.01% | 329 |
|
|
2023
Q1 | $57.1K | Sell |
80,754
-3,246
| -4% | -$2.3K | 0.01% | 361 |
|
|
2022
Q4 | $63K | Sell |
84,000
-61,000
| -42% | -$45.8K | 0.01% | 336 |
|
|
2022
Q3 | $125K | Sell |
145,000
-17,000
| -10% | -$14.7K | 0.02% | 326 |
|
|
2022
Q2 | $186K | Buy |
162,000
+138,500
| +589% | +$159K | 0.02% | 327 |
|
|
2022
Q1 | $26K | Buy |
23,500
+6,500
| +38% | +$7.19K | ﹤0.01% | 384 |
|
|
2021
Q4 | $27K | Buy |
+17,000
| New | +$27K | ﹤0.01% | 396 |
|